by Kall Kwik WGC | Dec 13, 2012 | Free Library
December, 2012 SMM-092 Excellence in market access strategy: A research-based definition and diagnostic tool Market access strategy is a pressing and important issue for almost all pharmaceutical and medical technology companies. Yet the content...
by Kall Kwik WGC | Nov 19, 2012 | Free Library
November, 2012 SMM-091 Access all areas Market Access is a major issue facing innovative medical technology companies. In this article, Professor Brian D Smith reveals the characteristics that differentiate strong market access strategies from...
by Kall Kwik WGC | Oct 17, 2012 | Free Library
October, 2012 SMM-089 Testing Times Most medtech firms find the annual business plan review an unsatisfactory process. Research into the few who do find the process beneficial reveals three valuable lessons.
by Kall Kwik WGC | Apr 18, 2012 | Free Library
March, 2012 SMM-087 Lifecycle management Product life cycle is a concept that is so familiar that we barely think about it; but at a time when business growth is harder than ever, understanding how this idea applies in medical technology markets...
by Kall Kwik WGC | Apr 18, 2012 | Free Library
April, 2012 SMM-088 Superior segmentation As patients and payers join in the prescribing decision, the industry needs new models of definition.
